[SPECT (single photon emission computed tomography) findings in 4 cases of neuronal migration disorders].

No To Shinkei

Department of Pediatrics, Tokyo Jikei University School of Medicine, Aoto Hospital, Japan.

Published: January 1993

We report SPECT findings in four children with various types of neuronal migration disorders. SPECT of a patient with heterotopia showed a protrudent abnormal shadow into the centrum semiovale, the density of which was same as that of normal gray matter. The function and the metabolism of heterotopia appear same as those of the normal gray matter. SPECT of a patient with pachygyria showed decreased blood flow in the areas of thickened cortex. This finding seems to indicate hypofunction of those lesions. SPECT of a patient with hemimegalencephaly showed an increased blood flow in the ipsilateral hemisphere and decreased blood flow in the contra-lateral hemisphere. In the literature, increased contents of neuronal elements in the affected site and arterio-venous shunt with cardiac failure have been reported in hemimegalencephaly. These pathologies may be related to our SPECT findings. SPECT of a patient with cortical dysplasia showed extensive lesions of decreased blood flow which was more wide spread than abnormal lesions detected by MRI. SPECT may be more sensitive than MRI to detect cortical dysplasias.

Download full-text PDF

Source

Publication Analysis

Top Keywords

spect patient
16
blood flow
16
decreased blood
12
neuronal migration
8
spect findings
8
normal gray
8
gray matter
8
spect
7
[spect single
4
single photon
4

Similar Publications

Background: In Japan, the number of patients with dementia is increasing and there is a shortage of human resources who can conduct detailed psychological examinations, and the development and implementation of new tools is essential for improving dementia care. Japan is one of seven sites across the globe focusing on healthcare system preparedness as part of the Davos Alzheimer's Collaborative Early Detection flagship program. As part of this program, Japan implemented new tools including a digital cognitive assessment (DCA) and blood-based biomarker (BBM) to increase rates of early detection of cognitive impairment.

View Article and Find Full Text PDF

False-Positive Uptake of 123I-MIBG in the Basal Ganglion in a Pediatric Neuroblastoma Patient.

Clin Nucl Med

January 2025

From the Department of Nuclear Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing, China.

A 7-year-old boy with high-risk neuroblastoma underwent 123I-MIBG SPECT/CT to evaluate the therapy response. The scan revealed abnormal 123I-MIBG uptake in the left basal ganglion, indicating the possibility of brain metastasis. Subsequent contrast-enhanced brain MRI, however, did not show any abnormal signal intensity in the left basal ganglion.

View Article and Find Full Text PDF

Breast cancer presents a significant global health challenge, necessitating continued innovation in diagnostic and therapeutic approaches. Recent advances have led to the identification of cancer-associated fibroblasts, which are highly prevalent in breast cancers and express fibroblast activation proteins (FAPs), as critical targets. FAP-specific radiotracers, when used with PET/CT and SPECT/CT, have significant potential for improving early breast cancer detection, staging, treatment response monitoring, and therapeutic intervention.

View Article and Find Full Text PDF

Development of Tc-Labeled Complexes with a Niraparib HYNIC Derivative for PARP-Positive Tumor Imaging.

Mol Pharm

January 2025

Key Laboratory of Radiopharmaceuticals of the Ministry of Education, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), College of Chemistry, Beijing Normal University, Beijing 100875, P. R. China.

As an enzyme that plays an important role in DNA repair, poly(ADP-ribose) polymerase-1 (PARP-1) has become a popular target for cancer therapy. Nuclear medicine molecular imaging technology, supplemented by radiolabeled PARP-1 inhibitors, can accurately determine the expression level of PARP-1 at lesion sites to help patients choose an appropriate treatment plan. In this work, niraparib was modified with a hydrazinonicotinamide (HYNIC) group to generate the ligand NPBHYNIC, which has an affinity (IC) of 450.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!